Glimiwin MV2 Tablet
Manufacturer
Docwin Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg)
Key Information
Short Description
Glimiwin MV2 Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Dosage Form
Tablet
Introduction
Glimiwin MV2 Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimiwin MV2 Tablet is to be taken empty stomach.
Safety Information
Side Effects
No common side effects listed.
Alcohol Warning
It is unsafe to consume alcohol with Glimiwin MV2 Tablet.
Breastfeeding Warning
Glimiwin MV2 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy Warning
Glimiwin MV2 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Glimiwin MV2 Tablet is a combination of three antidiabetic medicines:
Quick Tips
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Related Medicines
Gemer V2 Tablet
Vogli-GM 2 Tablet
Voglivil 2mg/500mg/0.2mg Tablet
Briglim MV 2mg/500mg/0.2mg Tablet
Ozomet-PG 2mg/500mg/0.2mg Tablet
Glimigen-MV2 Tablet
Vogway gm 2mg/500mg/0.2mg Tablet
M Pride V 2/0.2mg Tablet
Emvose Trio 2 mg/500 mg/0.2 mg Tablet
Nuvogli Trio 2mg Tablet
Frequently asked questions
What is Glimiwin MV2 Tablet?
Glimiwin MV2 Tablet contains Glimepiride, Metformin, and Voglibose. It's used to treat Type 2 diabetes mellitus (DM). This medication improves blood glucose levels when taken with diet and exercise. Glimepiride increases insulin release from the pancreas. Metformin decreases glucose production in the liver and enhances insulin sensitivity. Voglibose inhibits alpha-glucosidase, lowering postprandial (after meal) glucose levels.
What are the possible side effects of Glimiwin MV2 Tablet?
Glimiwin MV2 Tablet can cause common side effects such as hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Are there any specific conditions under which Glimiwin MV2 Tablet should not be taken?
Glimiwin MV2 Tablet should not be taken by individuals with known allergies to its components or excipients. Patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcers, and underlying metabolic acidosis (including diabetic ketoacidosis) should avoid this medication.
Is it safe to drink alcohol while I am also taking Glimiwin MV2 Tablet?
No, drinking alcohol with Glimiwin MV2 Tablet is not advisable. It can lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Can Glimiwin MV2 Tablet cause hypoglycemia?
Yes, Glimiwin MV2 Tablet can induce hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. This is more likely to occur if you miss meals, drink alcohol, over-exercise, take other antidiabetic medications simultaneously, or have delayed blood sugar monitoring.
What are the instructions for storage and disposal of Glimiwin MV2 Tablet?
Store Glimiwin MV2 Tablet in its original container, tightly sealed. Follow the instructions provided on the packaging or label. Discard unused medication and ensure it is inaccessible to pets, children, and others.
